BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 08/12/22

It's been a stellar month+ for the more aggressive and leveraged equity CEFs with the more defensive option-income CEFs having more mixed results. Generally speaking, option-income CEFs that sell a low percentage of options against their portfolio have performed better than option fun...

BST and BSTZ are both funds invested purely in tech plays. BST has traditionally focused on larger, more established names but has added more speculative names. Both funds are having a challenging time navigating through this tech sell-off that continues to rage on. Wr...

It has been a while since I've provided an update on my top ten CEF positions. This year hasn't been too kind, but hard to complain when the last few years were so strong. Tech has been the biggest challenge for my portfolio, but there is very little working outside of energy. ...

BST yields 8.96%, BSTZ yields 10.98%. Both pay monthly. BSTZ has an 11.5% discount, BST has a 1.5% discount. Looking for a contrarian income investment? Sometimes that's necessary in order to find value. Why buy at a premium when you can buy at a discount? When buying cl...

The worst half to a year in a half-century is over, with the S&P 500 down -20.0% through June 30. What's in store for the second half? Well, that depends on whose advice you trust, and frankly, there's something for everyone, from bullish recoveries to end-of-the-world type scenar...

We previously discussed Buffett's explanation for why smart people go broke. We then made the connection to why we generally don't buy CEFs. However, this does not mean that investors should never buy any CEFs under any circumstances. Back in March, we wrote : ...

AIO has been beaten down significantly this year as tech continues to go deeper into bear market territory. The fund is at a deep discount on top of these declines that exaggerated the losses. The fund takes a hybrid approach to invest in the 'tech' space through convertible, equi...

BSTZ is a technology equities CEF with a global allocation mandate. The fund achieved stellar results in 2020 and 2021, stimulated by a zero rates environment and a voracious appetite for growth names from the investment community. Down almost -50% year to date, BSTZ is the victim...

I had put a lot of my cash to work in the month of May as equities hit new lows for the year. The S&P 500 briefly joined the Nasdaq in bear territory but swiftly bounced out of the technical bear market of a 20% decline. While I'm lighter on my cash allocation, the cash pile w...

BMEZ has been getting hit significantly, with the biotech and growth space moving sharply lower. Despite these pressures, I believe that BMEZ is attractive given its current discount and selloff. With our recent update on BlackRock Science & Technology Trust II, the fund's dis...